176 related articles for article (PubMed ID: 12512908)
1. Suppression of the Th2 pathway by suplatast tosilate in patients with perennial nasal allergies.
Furukido K; Takeno S; Ueda T; Hirakawa K; Yajin K
Am J Rhinol; 2002; 16(6):329-36. PubMed ID: 12512908
[TBL] [Abstract][Full Text] [Related]
2. CD28 and secretory immunoglobulin A-dependent activation of eosinophils: inhibition of mediator release by the anti-allergic drug, suplatast tosilate.
Woerly G; Decot V; Loiseau S; Loyens M; Chihara J; Ono N; Capron M
Clin Exp Allergy; 2004 Sep; 34(9):1379-87. PubMed ID: 15347370
[TBL] [Abstract][Full Text] [Related]
3. Topical suplatast tosilate (IPD) ameliorates Th2 cytokine-mediated dermatitis in caspase-1 transgenic mice by downregulating interleukin-4 and interleukin-5.
Murakami T; Yamanaka K; Tokime K; Kurokawa I; Tsutsui H; Nakanishi K; Mizutani H
Br J Dermatol; 2006 Jul; 155(1):27-32. PubMed ID: 16792748
[TBL] [Abstract][Full Text] [Related]
4. Suplatast tosilate affects the initial increase in specific IgE and interleukin-4 during immunotherapy for perennial allergic rhinitis.
Washio Y; Ohashi Y; Tanaka A; Kakinoki Y; Sugiura Y; Sakamoto H; Yamada K; Matsuda M; Uekawa M; Okamoto H; Nakai Y
Acta Otolaryngol Suppl; 1998; 538():126-32. PubMed ID: 9879412
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effects of suplatast tosilate on the differentiation and function of monocyte-derived dendritic cells from patients with asthma.
Tanaka A; Minoguchi K; Samson KT; Oda N; Yokoe T; Tazaki T; Yamamoto Y; Yamamoto M; Ohta S; Adachi M
Clin Exp Allergy; 2007 Jul; 37(7):1083-9. PubMed ID: 17581203
[TBL] [Abstract][Full Text] [Related]
6. The effects of suplatast tosilate (IPD-1151T) on innate immunity and antigen-presenting cells.
Hsu LW; Yang CH; Goto S; Nakano T; Lai CY; Lin YC; Kao YH; Chen SH; Cheng YF; Jawan B; Chiu KW; Tsao FK; Chen CL
Transpl Immunol; 2007 Nov; 18(2):108-14. PubMed ID: 18005853
[TBL] [Abstract][Full Text] [Related]
7. Effect of suplatast tosilate on goblet cell metaplasia in patients with asthma.
Hoshino M; Fujita Y; Saji J; Inoue T; Nakagawa T; Miyazawa T
Allergy; 2005 Nov; 60(11):1394-400. PubMed ID: 16197471
[TBL] [Abstract][Full Text] [Related]
8. [Cytokine production by peripheral blood mononuclear cells in bronchial asthma treated with suplatast tosilate].
Yamasawa H; Oshikawa K; Sugiyama Y
Arerugi; 2001 Jun; 50(6):513-9. PubMed ID: 11517513
[TBL] [Abstract][Full Text] [Related]
9. Selective enhancement of production of IgE, IgG4, and Th2-cell cytokine during the rebound phenomenon in atopic dermatitis and prevention by suplatast tosilate.
Kimata H
Ann Allergy Asthma Immunol; 1999 Mar; 82(3):293-5. PubMed ID: 10094221
[TBL] [Abstract][Full Text] [Related]
10. Time-dependent cytokine deviation toward the Th2 side in Japanese multiple sclerosis patients with interferon beta-1b.
Ochi H; Feng-Jun M; Osoegawa M; Minohara M; Murai H; Taniwaki T; Kira J
J Neurol Sci; 2004 Jul; 222(1-2):65-73. PubMed ID: 15240198
[TBL] [Abstract][Full Text] [Related]
11. Beneficial effects of suplatast tosilate (IPD-1151T) in a rat cystitis model induced by intravesical hydrochloric acid.
Kirimoto T; Nakano K; Irimura K; Hayashi Y; Matsuura N; Kiniwa M; Oka T; Yoshimura N
BJU Int; 2007 Oct; 100(4):935-9. PubMed ID: 17714534
[TBL] [Abstract][Full Text] [Related]
12. Suplatast tosilate alters DC1/DC2 balance in peripheral blood in bronchial asthma.
Yokomura K; Suda T; Matsuda H; Hashizume H; Asada K; Suzuki K; Chida K
J Asthma; 2005 Sep; 42(7):567-70. PubMed ID: 16169790
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of suplatast tosilate, a Th2 cytokine inhibitor based on the Th1/Th2 ratio for allergic disease in children: a retrospective study.
Yoshihara S; Fukuda H; Arisaka O
Arzneimittelforschung; 2011; 61(7):421-4. PubMed ID: 21899211
[TBL] [Abstract][Full Text] [Related]
14. Effect of suplatast tosilate (IPD-1151T) on cytokine production by allergen-specific human Th1 and Th2 cell lines.
Oda N; Minoguchi K; Yokoe T; Hashimoto T; Wada K; Miyamoto M; Tanaka A; Kohno Y; Adachi M
Life Sci; 1999; 65(8):763-70. PubMed ID: 10466742
[TBL] [Abstract][Full Text] [Related]
15. Effects of glucan treatment on the Th1/Th2 balance in patients with allergic rhinitis: a double-blind placebo-controlled study.
Kirmaz C; Bayrak P; Yilmaz O; Yuksel H
Eur Cytokine Netw; 2005 Jun; 16(2):128-34. PubMed ID: 15941684
[TBL] [Abstract][Full Text] [Related]
16. [Inhibitory effect of suplatast tosilate on eosinophil migration].
Kobayashi Y; Nagata M; Yamamoto H; Sakamoto Y
Arerugi; 2000 Jul; 49(7):600-3. PubMed ID: 10944827
[TBL] [Abstract][Full Text] [Related]
17. Effect of an orally active Th2 cytokine inhibitor, suplatast on "atopic cough" tosilate.
Ishiura Y; Fujimura M; Yamamoto H; Nobata K; Ishiguro T; Ogawa H; Myou S
Arzneimittelforschung; 2008; 58(6):297-302. PubMed ID: 18677972
[TBL] [Abstract][Full Text] [Related]
18. Immunolocalization of cytokines in the nasal mucosa of normal and perennial rhinitic subjects. The mast cell as a source of IL-4, IL-5, and IL-6 in human allergic mucosal inflammation.
Bradding P; Feather IH; Wilson S; Bardin PG; Heusser CH; Holgate ST; Howarth PH
J Immunol; 1993 Oct; 151(7):3853-65. PubMed ID: 8376806
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of IFN-alpha on the expression of various TH2 cytokines in human CD4+ T cells.
Shibuya H; Hirohata S
J Allergy Clin Immunol; 2005 Jul; 116(1):205-12. PubMed ID: 15990796
[TBL] [Abstract][Full Text] [Related]
20. Th-2 type cytokine receptors in allergic rhinitis and in response to topical steroids.
Wright ED; Christodoulopoulos P; Small P; Frenkiel S; Hamid Q
Laryngoscope; 1999 Apr; 109(4):551-6. PubMed ID: 10201739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
